Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain

NCT01446419 is registered in ClinicalTrials.gov with Relievant Medsystems, Inc. as lead sponsor.

NCT NCT01446419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01446419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain
Lead sponsor
Relievant Medsystems, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2011
Completion date
March 31, 2016
Enrollment
225 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

low back pain